Literature DB >> 3028159

Inorganic phosphate inhibits sympathetic neurotransmission in canine saphenous veins.

Y Edoute, P M Vanhoutte, J T Shepherd.   

Abstract

Inorganic phosphate has been proposed as the initiator of metabolic vasodilatation in active skeletal muscle. The present study was primarily designed to determine if this substance has an inhibitory effect on adrenergic neurotransmission. Rings of canine saphenous veins were suspended for isometric tension recording in organ chambers. A comparison was made of the ability of inorganic phosphate (3 to 14 mM) to relax rings contracted to the same degree by electrical stimulation, exogenous norepinephrine, and prostaglandin F2 alpha. The relaxation during electrical stimulation was significantly greater at all concentrations of phosphate. In strips of saphenous veins previously incubated with [3H]norepinephrine, the depression of the contractile response caused by phosphate during electrical stimulation was accompanied by a significant reduction in the overflow of labeled neurotransmitter. Thus inorganic phosphate inhibits sympathetic neurotransmission and hence may have a key role in the sympatholysis in the active skeletal muscles during exercise. By contrast, in this preparation, it has a modest direct relaxing action on the vascular smooth muscle.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3028159     DOI: 10.1152/ajpheart.1987.252.1.H131

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  2 in total

1.  Is sympathetic neural vasoconstriction blunted in the vascular bed of exercising human muscle?

Authors:  Michael E Tschakovsky; Kittiphong Sujirattanawimol; Stephen B Ruble; Zoran Valic; Michael J Joyner
Journal:  J Physiol       Date:  2002-06-01       Impact factor: 5.182

2.  Functional and metabolic responses of the isolated rat heart to changes in circulating inorganic phosphate concentration.

Authors:  S M Humphrey; L C Armiger; D G Holliss; J E Buckman
Journal:  Heart Vessels       Date:  1988       Impact factor: 2.037

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.